ribociclib
novartis
['ribo', 'breast', 'ribociclib', 'bcsm']
ribociclib dose reductions do not affect survival outcomes in hr+/her2- advanced breast cancer #asco22 #bcsm #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.